ADMA cuts its 2026 outlook after Q1 revenues slip amid IG market pressure, though Asceniv demand and margins stay strong.
WHO's approval of the RTS,S/AS01 (Mosquirix) malaria vaccine in 2021 marked a milestone in global public health. It represented not only the first vaccine approved against any parasitic human disease ...